Part of Cancer staging guidance sheets
Lung (ICD10 C34)
Introduction
This is the data sheet for TNM 9th edition staging of the lung (ICD10 C34)
For more detailed information regarding TNM staging, please see pages 109-113 of the UICC TNM 9 book.
Stage groupings
|
Stage Group |
T stage |
N stage |
M stage |
|---|---|---|---|
|
Occult carcinoma |
TX |
N0 |
M0 |
|
Stage 0 |
Tis |
N0 |
M0 |
|
Stage IA1 |
T1mi |
N0 |
M0 |
|
|
T1a |
N0 |
M0 |
|
Stage IA2 |
T1b |
N0 |
M0 |
|
Stage IA3 |
T1c |
N0 |
M0 |
|
Stage IB |
T2a |
N0 |
M0 |
|
Stage IIA |
T1 |
N1 |
M0 |
|
|
T2b |
N0 |
M0 |
|
Stage IIB |
T1 |
N2a |
M0 |
|
|
T2 |
N1 |
M0 |
|
|
T3 |
N0 |
M0 |
|
Stage IIIA |
T1 |
N2b |
M0 |
|
|
T2 |
N2a |
M0 |
|
|
T3 |
N1, N2a |
M0 |
|
|
T4 |
N0, N1 |
M0 |
|
Stage IIIB |
T1 |
N3 |
M0 |
|
|
T2 |
N2b, N3 |
M0 |
|
|
T3 |
N2b |
M0 |
|
|
T4 |
N2a, N2b |
M0 |
|
Stage IIIC |
T3, T4 |
N3 |
M0 |
|
Stage IVA |
Any T |
Any N |
M1a, M1b |
|
Stage IVB |
Any T |
Any N |
M1c1, M1c2 |
TNM clinical classification
T - primary tumour
|
T value |
Description |
|---|---|
|
cTX |
Primary tumour cannot be assessed, or tumour proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy |
|
cT0 |
No evidence of primary tumour |
|
cTis |
Carcinoma in situa |
|
cT1 |
Tumour 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, or tumour in a lobar or more peripheral bronchusb cT1mi - Minimally invasive adenocarcinomac cT1a - Tumour 1 cm or less in greatest dimensionb cT1b - Tumour more than 1 cm but not more than 2 cm in greatest dimensionb cT1c - Tumour more than 2 cm but not more than 3 cm in greatest dimensionb |
|
cT2a |
Tumour more than 3 cm but not more than 4 cm in greatest dimension OR tumour not more than 4 cm in greatest dimension that invades one or more of the following • The main bronchus (up to the carina, but without involvement of the carina) • Invades visceral pleura • An adjacent lobe • Is associated with atelectasis or obstructive pneumonitis that extends to the hilar region either involving part of or the entire lung • Invades an adjacent lobe |
|
cT2b |
Tumour more than 4cm but no more than 5cm in greatest dimension |
|
cT3 |
Tumour more than 5 cm but not more than 7 cm in greatest dimension OR tumour not more than 7 cm that directly invades any of the following: Parietal pleura, chest wall (including superior sulcus tumours), pericardium, phrenic nerve, azygos veind , thoracic nerve roots (i.e., T1, T2), stellate ganglion or separate tumour nodule(s) in the same lobe as the primary |
|
cT4 |
Tumour more than 7 cm OR tumour of any size that invades any of the following: mediastinum, thymus, trachea, carina, recurrent laryngeal nerve, vagus nerve, oesophagus, diaphragm, heart, aorta, superior or inferior vena cava, intrapericardial pulmonary arteries or veins, supra-aortic arteries, brachiocephalic veins, subclavian vessels, vertebral body, lamina, spinal canal, cervical nerve roots, brachial plexus or separate tumour nodule(s) in a different ipsilateral lobe to that of the primary |
Notes:
General For non-mucinous lung adenocarcinomas, tumour size for the clinical T category is based on the size of the solid component seen on CT at lung windows (continuous thin section thickness, ≤1.5 mm) for part-solid nodules. At pathological assessment, if a nonmucinous adenocarcinoma has both lepidic and invasive components, the size of the invasive part is used for determining the pathological T category. For other tumour types, including invasive mucinous adenocarcinomas, the total tumour size is used both radiologically and pathologically in determination of the size descriptor of the T category.
Specific -
a Tis includes adenocarcinoma in situ – Tis(AIS) – and squamous carcinoma in situ – Tis (SCIS). Adenocarcinoma in situ by CT imaging should show a pure ground glass nodule ≤3.0 cm for cTis (AIS). For pTis (AIS), the tumour should be of pure lepidic growth without any invasion with a total size ≤3.0 cm, thus having an invasive size of 0 cm.
bThe uncommon superficial spreading tumour of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.
c Solitary adenocarcinoma (not more than 3 cm in greatest dimension), with a predominantly lepidic pattern and not more than 0.5 cm invasion in greatest dimension.
d Although these structures lie within the mediastinum invasion of these structure is not considered sufficient mediastinal penetration to be classified as a T4 category.
N - regional lymph nodes
|
N value |
Description |
|---|---|
|
cNX |
Regional lymph nodes cannot be assessed |
|
cN0 |
No regional lymph node metastasis |
|
cN1 |
Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and/or intrapulmonary nodes, including involvement by direct extension |
|
cN2 |
Metastasis in ipsilateral mediastinal and/or subcarinal lymph node station(s) cN2a – Metastasis in a single station cN2b – Metastasis in multiple ipsilateral stations |
|
cN3 |
Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) |
M - distant metastasis
|
M value |
Description |
|---|---|
|
cM0 |
No distant metastasis |
|
M1 |
Distant metastasis cM1a - Separate tumour nodule(s) in a contralateral lobe, tumour with pleural or pericardial nodules or malignant pleural or pericardial effusione cM1b - Single extrathoracic metastasis in a single organ or organ systemf cM1c - Multiple extrathoracic metastasis in a single or multiple organ(s) or organ system cM1c1 - Multiple extrathoracic metastasis in a single organ or organ system cM1c2 - Multiple extrathoracic metastasis in multiple organs or organ system(s) |
Notes
eMost pleural (pericardial) effusions with lung cancer are due to the tumour. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumour, and the fluid is non‐bloody and is not an exudate. Where these elements and clinical judgment dictate that the effusion is not related to the tumour, the effusion should be excluded as a staging descriptor.
fThis includes the involvement of a single non-regional node.
TNM pathological classification
pT - primary tumour
The pT and pN categories correspond to the cT and cN categories as per above.
pN - regional lymph nodes
|
pN value |
Description |
|---|---|
|
pN0 |
Histological examination of hilar and mediastinal lymphadenectomy specimen(s) will ordinarily include 6 or more lymph node stations. Three of these stations should be mediastinal, including the subcarinal nodes and three from N1 stations. Labelling according to the IASLC chart and table of definitions given in the TNM Supplement is desirable. If all the lymph nodes examined are negative, but the number ordinarily examined is not met, classify as pN0. |
Last edited: 19 January 2026 12:13 pm